Gallimore Godkin Lab

The Gallimore Godkin Cancer Immunology Lab. Researching the complex interactions between the Immune System and Cancer.

[Gallimore Godkin Lab @GallimoreGodkin]

Our lab are delighted that the Bowelbabe Fund for CRUK is supporting our research into bowel cancer vaccines and are incredibly humbled by the support shown to us by Dame Deborah James’s family. We are fuelled by science and Rebellious Hope

Thank you @BowelbabeF @CR_UK https://t.co/aV5fjBuBlu

[Gallimore Godkin Lab @GallimoreGodkin]

Our new study provides evidence that intermittent dosing with combinations of immunotherapy drugs have fewer side effects but are equally effective at controlling tumours. Changing dosing regimes may benefit patients receiving immunotherapies.

https://t.co/aCxdvzEDYw

[Gallimore Godkin Lab @GallimoreGodkin]

Read our recent article just published in Cell Reports Methods! “OSCAR is an online ML-powered tool for organoid cell counting using bright-field images” @CellRepMethods https://t.co/xV31S73CJp

[Gallimore Godkin Lab @GallimoreGodkin]

🔬 Interested in AI + cancer research? Come join our lab and CUBRIC for a Fully Funded PhD Studentship (3.5 years or part-time equivalent).

More info below apply here: https://t.co/uje6vkxzu4

[Wales Cancer Research Centre @theWCRC]

Dr @Mat_Clement's achievement of a @BrainTumourOrg Future Leaders Fellowship is a source of immense pride for @theWCRC, it epitomises the aspirations we hold for our funded researchers.

Llongyfarchiadau/Congratulations Mat! 👏📷

https://t.co/JR2a41ehn9

[Wales Cancer Research Centre @theWCRC]

The @theWCRC team thoroughly enjoyed being part of the @ResearchWales conference today, some really interesting presentations around the theme ‘Research Matters’ and we got to test out our human flow cytometer (it’s harder than it looks!!)

[Gallimore Godkin Lab @GallimoreGodkin]

Our article, "Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers," is now a top 10 most-cited paper in @immunology! #TopCitedArticle

[Gallimore Godkin Lab @GallimoreGodkin]

We are excited to share new research from our group! A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation. @CellReports
https://t.co/jHsRp9CLO1

[Science and Innovation at Cancer Research UK @CRUKresearch]

Are you a #CRUKfunded postdoc interested in establishing your independence?

Don’t miss #PostdocFutures24 to pick up the practical tips you need to take the next step in your career.

Register now https://t.co/YwYMCFn55f

#CRUKpostdocs

[Discovery Immunology Journal @discovimmunol]

We're proud to feature top articles on #tumour antigens, CD8 #Tcell migration, #NKG2D & more! 🙌

Catch up on the latest #cancer research this #WorldCancerDay in this Virtual Issue for ⬇️

[Gallimore Godkin Lab @GallimoreGodkin]

Our article 'T Cell Activation Drives Useful Tumour HEV' published in @discovimmunol has been featured in @britsocimm’s #WorldCancerDay Virtual Issue! Catch up on cutting-edge cancer #immunology & #immunotherapy research here: https://t.co/tMLhlX2ISg

[Gallimore Godkin Lab @GallimoreGodkin]

We were thrilled to be part of the recent @cardiffuni Cancer Symposium. A joint effort led by @CUSystemsImmu @CUCancerInst @theWCRC @ECMC_UK that showcased a wealth of knowledge, diverse range of studies and fostering of new collaborations. Find out more: https://t.co/64ZN3YqiY2

[Gallimore Godkin Lab @GallimoreGodkin]

Read our recent review just published in Discovery Immunology! "The Link between T cell Activation and Development of Functionally Useful Tumour Associated High Endothelial Venules" https://t.co/FRWvZ6hP9B
@paxsm7

[Gallimore Godkin Lab @GallimoreGodkin]

We are excited to share new research from our group! 3D imaging of HEV dynamics in lymph nodes and tumours during immunotherapy. @CRC_AACR @paxsm7

https://t.co/5aZxOjoMjO

[Cardiff Alumni | Cynfyfyrwyr Caerdydd @CardiffAlumni]

Questions about #cancer? Profs Awen Gallimore & Andrew Godkin will be here to answer questions and talk about the exciting research taking place @CardiffUni. Join us 8 June 5.15pm @GallimoreGodkin @CUSystemsImmu https://t.co/yk3yd4fiwo

[Gallimore Godkin Lab @GallimoreGodkin]

Thanks to funding through the Sêr Cymru we can tackle #COVIDー19 using structural studies of TCRs bound to peptide-MHC class II to inform #COVIDー19 #vaccine design @MacLachlanBJ! Congrats to all applicants, who will contribute to the advancement of #COVIDー19 #research

[Cardiff University @cardiffuni]

#CardiffUni has won £1m in Sêr Cymru research grants to tackle the challenges of Covid-19.
https://t.co/DQtUrrNU7J

[Dr. Ceri Fielding @CeriFielding]

Great T-reg directed immunotherapy talk from Sarah Lauder of @GallimoreGodkin group. Virtual annual meeting, Division of Infection & Immunity & @CUSystemsImmu , Cardiff University.

[BSI South Wales @ImmunoSW]

Congratulations to Miss Rubina, Dr Curtis, Miss Nasarre and Dr Bliss as winners for posters and talks in the Infection and Immunity Annual Meeting 2020 @cardiffuni @CUSystemsImmu @carlymaybliss @GallimoreGodkin

[Systems Immunity Research Institute @CUSystemsImmu]

The latest update of our Covid-19 literature review is now available online, edition no. 26:

- Immunopathology
- T cells, B cells and immunological memory
- Genetic variants and disease
- Virology
- Therapeutics and PPE
- Neuropathology

https://t.co/wKQDTgzupP

@GallimoreGodkin